Disclosure Of Earnings Per Share [Text Block]

ABIONYX Pharma - Filing #2813091

Concept 2022-01-01 to
2022-12-31
2021-01-01 to
2021-12-31
Disclosure of earnings per share [text block]
Soldes et explications
Earnings per share [text block]
Earnings per share [abstract]
Earnings per share [line items]
Basic earnings per share [abstract]
Basic earnings (loss) per share
15.00
23.00
Diluted earnings per share [abstract]
Diluted earnings (loss) per share
15.00
23.00
Weighted average ordinary shares used in calculating basic and diluted earnings per share [abstract]
Weighted average number of ordinary shares used in calculating basic earnings per share
27 967 014 xbrli:shares
24 879 858 xbrli:shares
Weighted average number of ordinary shares used in calculating diluted earnings per share
29 859 811 xbrli:shares
25 918 505 xbrli:shares
Increase (decrease) in number of ordinary shares issued
437 500 xbrli:shares
3 271 610 xbrli:shares
Disclosure of depositary receipts [text block]
Disclosure of depositary receipts [abstract]
Disclosure of depositary receipts [line items]

Talk to a Data Expert

Have a question? We'll get back to you promptly.